Showing results (71-80 of 282) with videos related to
Sort By:
Pageof 29
Cancer Letters|May 5, 2015
Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cellsWeilong Yao, Ping Yue, Guojing Zhang, et al.The Journal of Biological Chemistry|May 14, 2005
SNAP-29-mediated modulation of synaptic transmission in cultured hippocampal neuronsPing-Yue Pan, Qian Cai, Lin Lin, et al.Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|October 18, 2011
Randomized clinical trial of single-incision versus conventional laparoscopic cholecystectomy: short-term operative outcomesZhan Guo Cao, Wang Cai, Ming Fang Qin, et al.Molecular Pharmacology|August 9, 2007
CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cellsShuzhen Chen, Xiangguo Liu, Ping Yue, et al.Human Vaccines & Immunotherapeutics|December 6, 2022
Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysisQi Cai, Geng-Wei Huo, Fu-Yi Zhu, et al.International Journal of Oncology|June 15, 2006
A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancerLuo Wang, Jie Wang, Shiyong Sun, et al.Molecular Cancer|February 2, 2010
Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosisShuzhen Chen, Lei Fu, Shruti M Raja, et al.Cancer Biology & Therapy|April 23, 2005
Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrationsShi-Yong Sun, Claudia P Schroeder, Ping Yue, et al.NPJ Parkinson'S Disease|August 8, 2024
Parkinson's disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporterJacqueline Saenz, Elnaz Khezerlou, Meha Aggarwal, et al.Research Square|November 24, 2025
Synaptojanin-1 supports VPS35-dependent trafficking of dopamine D2 autoreceptors at presynaptic terminalsNirmal Kumar, Elnaz Khezerlou, Justin Cai, et al.Pageof 29